Abbvie Inc (ABBV) Stock Price, Graph, News & Analysis
Manufacturing (Pharmaceutical Preparation Manufacturing ) | NEW YORK STOCK EXCHANGE INC. : ABBV
$151.01 -$0.71 (-0.47%)
Market Status : Closed
Last Update :
5/20/2022 4:03:24 PM
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact Read More
Historical Price Graph
Performance
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year |
|---|---|---|---|---|---|---|
| -2.57% | 4.63% | 33.05% | 13.64% | 35.61% | 79.64% | 190.04% |
Details
Exchange
NEW YORK STOCK EXCHANGE INC.
Industry
Pharmaceutical Preparation Manufacturing
Website
www.abbvie.com
Sector
Manufacturing
CEO
Richard Gonzalez
Total Employees
2,022
SIC Code
2834
Market Cap
$ 266.85 B
Key Statistics
Dividend Rate
$5.34
Last Dividend
2022-04-13
Dividend Yield
3.54%
P/E Ratio
21.63
Price Range (52 Week)
$102.35 - $174.43
Latest Volume
$ 5.41 M
Average Total Volume
$ 7.57 M
Outstanding Shares
1,767,110,083
Beta
34.7%
Similar Stocks
| Companyarrow_upward | Sectorarrow_upward | Latest Pricearrow_upward | Changearrow_upward |
|---|---|---|---|
| Coca-Cola Co (KO) | Consumer Non-Durables | $60.98 | $0.98 |
| Vanguard Group, Inc. - Vanguard Total Stock Market ETF (VTI) | Miscellaneous | $195.32 | $0.00 |
| Vanguard Group, Inc. - Vanguard S&P 500 ETF (VOO) | Miscellaneous | $358.02 | $0.09 |
| Merck & Co Inc (MRK) | Health Technology | $93.55 | $1.46 |
| PepsiCo Inc (PEP) | Consumer Non-Durables | $162.21 | $1.01 |
Abbvie Inc in News
Seeking Alpha (ABBV)
AbbVie Stock: What To Know Ahead Of Upcoming Earnings (NYSE:ABBV) AbbVie is set to report highly-anticipated earnings this week. The stock has been terrific this year Apr 27, 2022 8:35 AM
Benzinga (TEVA,TEVA-IT,W8A-GD,W8A-GH,W8A-GB,W8A-GM,W8A-GI,W8A-GS,W8A-GF,W8A-GY,WBA,ABBV)
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters San Francisco will start a trial against Walgreens Boots Alliance Inc (NASDAQ: WBA ) and three other Apr 25, 2022 4:11 PM
Kwhen Finance (UL,FB,ABBV)
Outlook on the Skin Boosters Global Market to 2027 - Featuring Teoxane, IBSA Institut Biochimique and Galderma Among Others - ResearchAndMarkets.com Apr 21, 2022 9:43 AM
Benzinga (ABBV,LLY,YPSN-SE,YPSN-SR)
Autoinjectors Market | Home Care Settings Segment is Estimated to Account for the Largest Share - MDC Research Pune, April 07, 2022 (GLOBE NEWSWIRE) -- Autoinjectors or auto-injector is a medical device, which i Apr 7, 2022 6:34 AM
Benzinga (ABBV)
Allergan Shares Topline Data For Twice Daily Vuity (Pilocarpine) In Blurry Vision Study Allergan , an AbbVie Inc (NYSE: ABBV ) company, announced topline data from Phase 3 VIRGO trial eval Apr 5, 2022 2:43 PM
Benzinga (VRTS,CVS,ABBV)
CNBC''s Final Trades: CVS Health, AbbVie And This Travel Stock On CNBC’s “ Halftime Report Final Trades ,” Joseph Terranova of Virtus Investment Partners recommend Apr 5, 2022 8:15 AM
OpenPR (PFE,AZN-LN,AZN,ZEGA-GD,ZEGA-GB,ZEGA-GM,ZEGA-GS,ZEGA-GF,AZNCF,AZN-SS,ABBV)
Focal Segmental Glomerulosclerosis Market Benefit and Volume 2022 with Status and Prospect to 2028 | AbbVie, Inc., Pfizer, Inc., AstraZeneca plc Coherent Market Insights has released a new research study on the "Focal Segmental Glomerulosclerosi Apr 4, 2022 7:12 AM
iCrowdNewswire (AMGN,ROG-SE,RHHBY,RO-SE,ABBV)
Biopharmaceuticals Market to See Huge Growth by 2028 | Roche, Amgen, AbbVie The Latest research study released by HTF MI “Global Biopharmaceuticals Market” with 100+ pages of a Apr 2, 2022 5:00 AM
OpenPR (AZN-LN,AZN,ZEGA-GD,ZEGA-GB,ZEGA-GM,ZEGA-GS,ZEGA-GF,AZNCF,AZN-SS,ABBV,BAX,0QK8-LN)
General Anesthesia Drugs Market Is Booming Worldwide 2022-2028 | Baxter International Inc., AstraZeneca, AbbVie Inc. Coherent Market Insights has released a new research study on the "General Anesthesia Drugs Market" Apr 1, 2022 7:12 AM
OpenPR (MRK,PFE,ABBV)
Global Adult Malignant Glioma Therapeutics Market 2022 to 2030 Huge Growth with Leading Players - Merck & Co., Inc, F. Hoffmann-La Roche Ltd, Arbor Pharmaceutical, Pfizer, Inc, AbbVie, Inc The "Global Adult Malignant Glioma Therapeutics Market Analysis to 2030" is a particular and top to Mar 31, 2022 5:27 AM
Common Questions Related to Abbvie Inc
When is Abbvie Inc next earning date?
Abbvie Inc next earning date is 2022-07-29
What is dividend yield of Abbvie Inc stock?
Abbvie Inc dividend yield is 0.035391346004776614 and Abbvie Inc announced last dividend in 2022-04-13 of amount $5.34/stock.
What is Abbvie Inc stock symbol?
Abbvie Inc traded in NEW YORK STOCK EXCHANGE INC. stock exchange and the stock symbol/ticker is ABBV
What is the latest share price of Abbvie Inc (ABBV)? or What is Abbvie Inc stock price today?
Abbvie Inc latest stock price is $151.01
Where is Abbvie Inc headquarter?
Abbvie Inc headquarter is at – 1 N Waukegan Rd, North Chicago, Illinois, US
What is the total market cap of Abbvie Inc company?
The total market value of Abbvie Inc stock is $ 266.85 B
What is the P/E ratio of Abbvie Inc stock?
Abbvie Inc P/E ratio is 21.50812393276618
What is the EPS of Abbvie Inc stock?
Abbvie Inc EPS is 6.98
What is the Beta of Abbvie Inc stock?
Abbvie Inc Beta is 0.34699548800478575
Related Tags
Abbvie Inc stock price history, Abbvie Inc stock quote, ABBV current stock price, Abbvie Inc dividend yield, Abbvie Inc Dividend, How much is Abbvie Inc worth